$942 Million is the total value of 683 Capital Management, LLC's 96 reported holdings in Q3 2016. The portfolio turnover from Q2 2016 to Q3 2016 was 22.6% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
EWY | Sell | ISHAREScall | $25,577,000 | -2.7% | 440,000 | -12.9% | 2.72% | -35.2% |
MU | Sell | MICRON TECHNOLOGY INC | $14,669,000 | +6.6% | 825,000 | -17.5% | 1.56% | -29.0% |
CC | Sell | CHEMOURS CO | $12,720,000 | +59.7% | 795,000 | -17.7% | 1.35% | +6.4% |
ENVA | Sell | ENOVA INTL INC | $11,189,000 | +16.9% | 1,155,900 | -11.1% | 1.19% | -22.1% |
SNR | Sell | NEW SR INVT GROUP INC | $11,186,000 | -31.5% | 969,363 | -36.6% | 1.19% | -54.4% |
EPI | Sell | WISDOMTREE TRcall | $11,026,000 | -23.6% | 510,000 | -28.7% | 1.17% | -49.1% |
GIS | Sell | GENERAL MLS INCput | $9,582,000 | -32.8% | 150,000 | -25.0% | 1.02% | -55.3% |
EWW | Sell | ISHARESput | $7,030,000 | -10.0% | 145,000 | -6.5% | 0.75% | -40.1% |
RPXC | Sell | RPX CORP | $6,647,000 | +3.6% | 621,757 | -11.2% | 0.71% | -31.0% |
RSX | Sell | VANECK VECTORS ETF TRcall | $6,003,000 | -4.3% | 320,000 | -11.1% | 0.64% | -36.3% |
DRRX | Sell | DURECT CORP | $4,170,000 | -5.8% | 3,000,000 | -17.3% | 0.44% | -37.3% |
NRZ | Sell | NEW RESIDENTIAL INVT CORP | $3,197,000 | -64.7% | 231,500 | -64.6% | 0.34% | -76.5% |
TACO | Sell | DEL TACO RESTAURANTS INC | $1,490,000 | +5.6% | 125,000 | -19.4% | 0.16% | -29.8% |
EWW | Sell | ISHARESmsci mex cap etf | $1,357,000 | -73.1% | 28,000 | -72.0% | 0.14% | -82.1% |
EWZ | Sell | ISHARESmsci brz cap etf | $1,315,000 | -56.0% | 39,000 | -60.6% | 0.14% | -70.6% |
Sell | GEVO INCnote 7.500% 7/0 | $1,255,000 | -29.8% | 6,275,000 | -16.6% | 0.13% | -53.3% | |
EZA | Sell | ISHARESmsci sth afr etf | $1,009,000 | -34.2% | 18,000 | -37.9% | 0.11% | -56.3% |
SGM | Sell | STONEGATE MTG CORP | $790,000 | -34.3% | 172,435 | -51.9% | 0.08% | -56.2% |
FXI | Sell | ISHARES TRchina lg-cap etf | $673,000 | -73.1% | 17,700 | -75.8% | 0.07% | -82.2% |
PTIE | Sell | PAIN THERAPEUTICS INC | $458,000 | -60.8% | 457,969 | -14.1% | 0.05% | -73.7% |
NVTRQ | Sell | NUVECTRA CORP | $418,000 | -26.3% | 60,400 | -21.1% | 0.04% | -51.1% |
VRTS | Sell | VIRTUS INVT PARTNERS INC | $391,000 | -60.8% | 4,000 | -71.4% | 0.04% | -73.6% |
WHLR | Sell | WHEELER REAL ESTATE INVT TR | $396,000 | -45.4% | 226,098 | -52.0% | 0.04% | -63.8% |
NPO | Sell | ENPRO INDS INC | $114,000 | -85.2% | 2,000 | -88.5% | 0.01% | -90.2% |
MDLY | Exit | MEDLEY MGMT INC | $0 | – | -15,500 | -100.0% | -0.02% | – |
ICON | Exit | ICONIX BRAND GROUP INC | $0 | – | -68,600 | -100.0% | -0.07% | – |
MBBYF | Exit | MOBILEYE N V AMSTELVEENput | $0 | – | -18,700 | -100.0% | -0.14% | – |
NGVT | Exit | INGEVITY CORP | $0 | – | -59,600 | -100.0% | -0.32% | – |
MA | Exit | MASTERCARD INCput | $0 | – | -200,000 | -100.0% | -2.81% | – |
EMC | Exit | E M C CORP MASS | $0 | – | -770,000 | -100.0% | -3.34% | – |
V | Exit | VISA INCput | $0 | – | -400,000 | -100.0% | -4.73% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2016-11-14
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
IRSA INVERSIONES Y REP S A | 42 | Q3 2023 | 2.9% |
CRESUD S A C I F Y A | 39 | Q3 2023 | 3.3% |
ENOVA INTL INC | 34 | Q3 2023 | 8.2% |
UNIQURE NV | 28 | Q3 2023 | 4.1% |
INSPIRED ENTMT INC | 28 | Q3 2023 | 2.3% |
MICRON TECHNOLOGY INC | 26 | Q1 2023 | 3.2% |
GALMED PHARMACEUTICALS LTD | 25 | Q1 2020 | 1.2% |
FENNEC PHARMACEUTICALS INC | 25 | Q3 2023 | 0.9% |
CARVANA CO | 24 | Q3 2023 | 14.2% |
ALNYLAM PHARMACEUTICALS INC | 24 | Q2 2022 | 3.2% |
View 683 Capital Management, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
AxonPrime Infrastructure Acquisition Corp | February 14, 2023 | 441,138 | 2.9% |
DIRTT ENVIRONMENTAL SOLUTIONS LTD | February 14, 2023 | 218,490 | - |
Hawks Acquisition Corp | February 14, 2023 | 1,979,592 | 8.6% |
MARINUS PHARMACEUTICALS, INC. | February 14, 2023 | 90,000 | 0.2% |
SQZ Biotechnologies Co | February 14, 2023 | 1,330,889 | 4.5% |
Trajectory Alpha Acquisition Corp. | February 14, 2023 | 1,484,799 | 8.6% |
Concord Acquisition Corp | September 26, 2022 | 1,550,649 | 5.5% |
Archer Aviation Inc.Sold out | February 14, 2022 | 0 | 0.0% |
Hippo Holdings Inc.Sold out | February 14, 2022 | 0 | 0.0% |
Joby Aviation, Inc.Sold out | February 14, 2022 | 0 | 0.0% |
View 683 Capital Management, LLC's complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-05-15 |
SC 13G | 2024-03-01 |
13F-HR | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
View 683 Capital Management, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.